Author

Lingaraja Jena

Scientific Manager, Excelra Knowledge Foundation - Cited by 534 - Bioinformatics

Biography

Dr. Lingaraja Jena, currently working has a resercher in Bioinformatics Centre, Biochemistry and Jamnalal Bajaj Tropical Disease Research Centre, MGIMS, Sevagram, Maharashtra, India, Research interests are Bioinformatics and Biochemistry 
Title
Cited by
Year
Virtual screening for potential inhibitors of NS3 protein of Zika virus
M Sahoo, L Jena, S Daf, S KumarGenomics & informatics 14 (3), 104, 2016201
77
2016
Identification of suitable natural inhibitor against influenza A (H1N1) neuraminidase protein by molecular docking
M Sahoo, L Jena, SN Rath, S KumarGenomics & informatics 14 (3), 96, 2016201
63
2016
Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug
L Jena, P Waghmare, S Kashikar, S Kumar, BC HarinathInternational journal of mycobacteriology 3 (4), 276-282, 2014201
57
2014
Understanding rifampicin resistance in tuberculosis through a computational approach
S Kumar, L JenaGenomics & informatics 12 (4), 276, 2014201
36
2014
Elucidating molecular interactions of natural inhibitors with HPV-16 E6 oncoprotein through docking analysis
S Kumar, L Jena, S Galande, S Daf, K Mohod, AK VarmaGenomics & informatics 12 (2), 64, 2014201
32
2014
In silico docking to explicate interface between plant-originated inhibitors and E6 oncogenic protein of highly threatening human papillomavirus 18
S Kumar, L Jena, M Sahoo, M Kakde, S Daf, AK VarmaGenomics & informatics 13 (2), 60, 2015201
25
2015
Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein
S Kumar, L Jena, K Mohod, S Daf, AK VarmaInterdisciplinary Sciences: Computational Life Sciences 7, 136-142, 2015201
24
2015
Comparative proteomic analysis of Mycobacterium tuberculosis strain H37Rv versus H37Ra
L Jena, S Kashikar, S Kumar, BC HarinathInternational Journal of Mycobacteriology 2 (4), 220-226, 2013201
23
2013
Study of mechanism of interaction of truncated isoniazid–nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach
L Jena, S Deshmukh, P Waghmare, S Kumar, BC HarinathInternational journal of mycobacteriology 4 (4), 276-283, 151
20
2015
Discovery of T-cell driven subunit vaccines from Zika virus genome: an immunoinformatics approach
D Pradhan, M Yadav, R Verma, NS Khan, L Jena, AK JainInterdisciplinary Sciences: Computational Life Sciences 9, 468-477, 2017201
16
2017
Anti-tuberculosis therapy: Urgency for new drugs and integrative approach
L Jena, BC HarinathBiomedical and Biotechnology Research Journal (BBRJ) 2 (1), 16-19, 2018201
15
2018
Genome-wide identification of potential biomarkers in multiple myeloma using meta-analysis of mRNA and miRNA expression data
A Katiyar, G Kaur, L Rani, L Jena, H Singh, L Kumar, A Sharma, P Kaur, ...Scientific reports 11 (1), 10957, 2021202
14
2021
Excretory secretory proteins released during growth of Mycobacterium tuberculosis (H37Ra), with diagnostic potential in pulmonary and extra pulmonary tuberculosis
P Waghmare, G Wankhade, L Jena, BC HarinathMycobact Dis 6, 215, 2016201
12
2016
Isoniazid with multiple mode of action on various mycobacterial enzymes resulting in drug resistance
L Jena, T Nayak, S Deshmukh, G Wankhade, P Waghmare, BC HarinathJ Infect Dis Ther 4 (5), 2332-0877.1000297, 2016201
12
2016
An in silico approach to identify potential inhibitors against multiple drug targets of Mycobacterium tuberculosis
S Kumar, P Sahu, L JenaThe International Journal of Mycobacteriology 8 (3), 252-261, 2019201
11
2019
Effect of single amino acid mutations on C-terminal domain of breast cancer susceptible protein 1
S Kumar, L Jena, M Sahoo, K Mohod, S Daf, AK VarmaInternational Journal of Bioinformatics Research and Applications 15 (4 …, 2019201
10
2019
Branching clonal evolution patterns predominate mutational landscape in multiple myeloma
A Farswan, L Jena, G Kaur, A Gupta, R Gupta, L Rani, A Sharma, L KumarAmerican Journal of Cancer Research 11 (11), 5659, 2021202
10
2021
Understanding ligands driven mechanism of wild and mutant aryl hydrocarbon receptor in presence of phytochemicals combating Parkinson’s disease: an in silico and in vivo study
SN Rath, L Jena, M PatriJournal of Biomolecular Structure and Dynamics 38 (3), 807-826, 2020202
9
2020
Inhibition of mycobacterial CYP125 enzyme by sesamin and β-sitosterol: an in silico and in vitro study
G Wankhade, S Kamble, S Deshmukh, L Jena, P Waghmare, BC HarinathBiomed Biotechnol Res J 1 (1), 49-54, 2017201
8
2017
hpvPDB: an online proteome reserve for human papillomavirus
S Kumar, L Jena, S Daf, K Mohod, P Goyal, AK VarmaGenomics & informatics 11 (4), 29, 2013201
8
2013

Referred From: https://scholar.google.com/citations?user=u06M-8MAAAAJ&hl=en

Cited by
Citations 534
h-index 12
i10-index 17
Recommended Journals
Open Access Journals